HitGen, Inc. Hits Day High with 7.29% Surge Amid Strong Market Activity

HitGen, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, with its stock price rising by 7.29%. The stock reached an intraday high of CNY 31.44, reflecting a strong performance against the backdrop of a -1.37% decline in the China Shanghai Composite index. Over the past week, HitGen has demonstrated impressive growth, with a 16.93% increase, while its year-to-date performance stands at 31.09%. The company has also outperformed the China Shanghai Composite over various time frames, including a remarkable 95.17% increase over the past year. Financial metrics indicate a robust operational performance, highlighted by a net profit growth of 114.98% and a pre-tax profit of CNY 43.75 million, which has surged by 150.73%. The operating cash flow reached its highest at CNY 204.8 million, and the return on capital employed (ROCE) is recorded at 8.01%. With a market capitalization of CNY 10,782 million, HitGen continues to solidify its position as a reliable performer in the market.